[1]
N. Vu and P. Pham, “Umbilical Cord Tissue-derived Mesenchymal Stem Cells Should be Considered as Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence”, BMRAT, vol. 8, no. 9, pp. 4583-4595, Sep. 2021.